Evonile Pharma Ltd.
1,824.50+137.8 (+8.17%)
23 Oct, 12:00 AM
Annual Reports and Financial Documents
Evonile Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
Corporate Announcements and Regulatory Filings
Evonile Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
- Notice Of Postal Ballot (02/2026-27) - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') Of Evonile Pharma Limited (Formerly Known As Novartis India Limited ('The Company').Intimation of the Notice of Postal Ballot (02/2026-27) dated October 08, 2026.
- Board Meeting Intimation for Consideration Of Raising Of Funds Through The Issuance Of Equity Shares Of The Company.Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/10/2026 ,inter alia, to consider and approve the raising of funds through ....
- Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026.Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....
- Intimation Of The Voting Results And The Scrutinizers Report For The 78Th Annual General Meeting Of The Company Held On Thursday, September 24, 2026.Intimation of the Voting Results and the Scrutinizers Report for the 78th Annual General Meeting of the Company held on Thursday, September 24, 2026.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationIntimation is hereby given that the Officials of the Company will be participating in the Conference / Meeting scheduled on Emerging India CEO Forum by Nuvama on Monday, September 28, 2026.
- Intimation Regarding The Newspaper Publication Made Regarding The Corrigendum Filed Dated September 18, 2026, For The Notice Of 78Th Annual General MeetingIntimation regarding the newspaper publication made regarding the Corrigendum filed dated September 18, 2026, for the Notice of 78th Annual General Meeting
Frequently Asked Questions
Where can I download the annual report of Evonile Pharma Ltd.?
Annual reports of Evonile Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Evonile Pharma Ltd.?
Quarterly earnings results and presentations of Evonile Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Evonile Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Evonile Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Evonile Pharma Ltd.?
Investor presentations and annual day presentations of Evonile Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Evonile Pharma Ltd.?
Corporate announcements and regulatory filings of Evonile Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Evonile Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Evonile Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Evonile Pharma Ltd.?
The ISIN (International Securities Identification Number) of Evonile Pharma Ltd. is INE234A01025. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Evonile Pharma Ltd. listed?
Evonile Pharma Ltd. is listed on NSE and BSE. The NSE symbol is NOVARTIND and the BSE code is -.
Where can I find the shareholding pattern of Evonile Pharma Ltd.?
The quarterly shareholding pattern of Evonile Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Evonile Pharma Ltd. on Sharpely?
Share price data for Evonile Pharma Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.